Aspirin and simvastatin have beneficial effects in treating heart disease but offer no benefits to patients suffering from pulmonary artery hypertension (PAH).
PAH is a progressive, incurable disease, which is manifests with an increase in blood pressure in the arteries of the lungs, causing shortness of breath, dizziness and fatigue. It can lead to heart failure and death and occurs either on its own or in association with other conditions, such as congenital heart disease or connective tissue disease.
Read more at Newswise